Mitochondrial Dysfunction and Glaucoma
The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
Glaucoma is increasingly recognized as a neurodegenerative disorder, characterized by the accelerated loss of retinal ganglion cells (RGCs) and their axons. Open angle glaucoma prevalence and incidence increase exponentially with increasing age, yet the pathophysiology underlying increasing age as a risk factor for glaucoma is not well understood. Accumulating evidence points to age-related mitochondrial dysfunction playing a key role in the etiology of other neurodegenerative disorders including amyotrophic lateral sclerosis, Alzheimer and Parkinson disease. The 2 major functions of mitochondria are the generation of ATP through oxidative phosphorylation and the regulation of cell death by apoptosis. This review details evidence to support our hypothesis that age-associated mitochondrial dysfunction renders RGCs susceptible to glaucomatous injury by reducing the energy available for repair processes and predisposing RGCs to apoptosis. Eliciting the role of mitochondria in glaucoma pathogenesis may uncover novel therapeutic targets for protecting the optic nerve and preventing vision loss in glaucoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · cited 1×
“Cytochrome c, an important electron shuttle for the OXPHOS pathway in the mitochondrial intermembrane space, when released to the cytosol leads to the formation of the ‘‘apoptosome’’ complex that induces a cascade of caspase activation leading to protein and DNA degradation and finally apoptosis.(27,28) Activation of…”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Genetic and acquired mitochondrial dysfunction have been shown to play a role in physiologic aging and in the pathogenesis of a number of neurodegenerative diseases including Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, Huntington disease, and in mitochondrial diseases such as mitochondrial enc…”
BackgroundInduction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167 · cited 1×
“Cytochrome c, an important electron shuttle for the OXPHOS pathway in the mitochondrial intermembrane space, when released to the cytosol leads to the formation of the ‘‘apoptosome’’ complex that induces a cascade of caspase activation leading to protein and DNA degradation and finally apoptosis.(27,28) Activation of…”
BackgroundMitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Number of people with glaucoma worldwide.
Quigley, H. A. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.5.389 · Cited by 2,998
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“These mice exhibit overt signs of aging including alopecia, osteoporosis, and cardiomyopathy at much younger ages and have a shortened life span compared with wild-type control mice with a fully functional POLG gene.(47,48) Surprisingly, markers of lipid, protein, and DNA oxidation in muscle and liver were not increas…”
BackgroundMitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165
Normal oxidative damage to mitochondrial and nuclear DNA is extensive.
Richter, C., Park, J. W., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6465 · Cited by 1,725
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
Turrens, J. F., & Boveris, A. (1980) · Biochemical Journal · doi:10.1042/bj1910421 · Cited by 1,601
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446
Maternal inheritance of human mitochondrial DNA.
Giles, R. E., Blanc, H., Cann, H. M., & Wallace, D. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6715 · Cited by 1,365 · cited 1×
“Mitochondria are unique in that they retain a remnant genome from the endosymbiotic bacterium precursor, with the inheritance of its DNA [mitochondria DNA (mtDNA)] following the maternal line.(7) The mtDNA is a closed circular molecule 16.”
BackgroundTargeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173 · cited 1×
“As mitochondria is a major site of ROS production, advances have also been made in targeting antioxidants directly to within the mitochondria using techniques such as conjugating antioxidants to lipophilic cations with some success.(62,63) More robust neuroprotection may be derived from alternative strategies such as…”
Olichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer, P., & Lenaers, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200677200 · Cited by 1,168 · cited 1×
“Downregulation of OPA1 in HeLa cells by RNA interference causes fragmentation of the mitochondrial network, loss of mitochondrial membrane potential followed by release of cytochrome c, and activation of caspase-dependent apoptosis.(34) Mutations in OPA1 in ADOA increase the susceptibility of RGC to apoptogenic stimul…”
BackgroundThe Toxic Effect of Sodium L-Glutamate on the Inner Layers of the Retina
LUCAS, D. R., & NEWHOUSE, J. P. (1957) · Archives of Ophthalmology · doi:10.1001/archopht.1957.00940010205006 · Cited by 1,063
Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 971
Prevalence of Open-angle Glaucoma in Australia
Mitchell, P., Smith, W., Attebo, K., & Healey, P. R. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30449-1 · Cited by 959
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890
Cadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855 · cited 1×
“The major sites of ROS generation are at complex I and complex III, and free radical production is increased by inhibition of electron transport through the OXPHOS pathway.(8,9) Consequently, decline or inhibition in OXPHOS can result in 2 distinct pathogenic consequences; decline in ATP production and increase in ROS…”
BackgroundMitochondrial dysfunction as a cause of optic neuropathies
Carelli, V., Ross-Cisneros, F. N., & Sadun, A. A. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.003 · Cited by 839
Anson, R. M., Guo, Z., de Cabo, R., Iyun, T., Rios, M., Hagepanos, A., Ingram, D. K., Lane, M. A., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035720100 · Cited by 731
The Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences
Tezel, G. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.07.003 · Cited by 723
Elevated Glutamate Levels in the Vitreous Body of Humans and Monkeys With Glaucoma
Dreyer, E. B. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130295012 · Cited by 659
The mitochondrial energy transduction system and the aging process
Navarro, A., & Boveris, A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00213.2006 · Cited by 646
Cell death in the nervous system
Bredesen, D. E., Rao, R. V., & Mehlen, P. (2006) · Nature · doi:10.1038/nature05293 · Cited by 636
Chen, H., Pellegrini, J., Aggarwal, S., Lei, S., Warach, S., Jensen, F., & Lipton, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04427.1992 · Cited by 629
Szatkowski, M., & Attwell, D. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90040-x · Cited by 622
Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons
Tymianski, M., Charlton, M., Carlen, P., & Tator, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-05-02085.1993 · Cited by 567
Orgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J., & Forette, F. (2002) · Stroke · doi:10.1161/01.str.0000020094.08790.49 · Cited by 539 · cited 1×
“and mild-to-moderate vascular dementia.(88) A large-scale randomized study on memantine and visual field protection in glaucoma patients is near completion.”
BackgroundIntraocular pressure in an American community. The Beaver Dam Eye Study.
Klein, R., Klein, R., & Linton, K. L. P. (1992) · PubMed · Cited by 511
Ricci, J.-E., Gottlieb, R. A., & Green, D. R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208089 · Cited by 504
Mitochondria, the killer organelles and their weapons
Ravagnan, L., Roumier, T., & Kroemer, G. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10111 · Cited by 483
Prevalence of open-angle glaucoma and ocular hypertension in Latinos
Varma, R., Ying-Lai, M., Francis, B. A., Nguyen, B. B.-T., Deneen, J., Wilson, M. R., & Azen, S. P. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.01.025 · Cited by 483
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
TUNEL-Positive Ganglion Cells in Human Primary Open-angle Glaucoma
Kerrigan, L. A. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100160201010 · Cited by 465
Targeting antioxidants to mitochondria: A new therapeutic direction
Sheu, S.-S., Nauduri, D., & Anders, M. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.10.007 · Cited by 414
Mitochondrial point mutations do not limit the natural lifespan of mice
Vermulst, M., Bielas, J. H., Kujoth, G. C., Ladiges, W. C., Rabinovitch, P. S., Prolla, T. A., & Loeb, L. A. (2007) · Nature Genetics · doi:10.1038/ng1988 · Cited by 404
Changes in aqueous humor dynamics with age and glaucoma
Gabelt, B. T., & Kaufman, P. L. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.10.003 · Cited by 377
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain
Lin, M. T. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.2.133 · Cited by 366
Susceptibility to Neurodegeneration in a Glaucoma Is Modified by Bax Gene Dosage
Libby, R. T., Li, Y., Savinova, O. V., Barter, J., Smith, R. S., Nickells, R. W., & John, S. W. M. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010004 · Cited by 358
Nitric Oxide Synthase in the Human Glaucomatous Optic Nerve Head
Neufeld, A. H. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150499009 · Cited by 342
Mitochondrial Abnormalities in Patients with Primary Open-Angle Glaucoma
Abu-Amero, K. K., Morales, J., & Bosley, T. M. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1639 · Cited by 337
Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine.
Vorwerk, C. K., Lipton, S. A., Zurakowski, D., Hyman, B. T., Sabel, B. A., & Dreyer, E. B. (1996) · PubMed · Cited by 281
Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family
Korsmeyer, S. J., Yin, X.-M., Oltvai, Z. N., Veis-Novack, D. J., & Linette, G. P. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00011-r · Cited by 272
Retinal vessel diameter and open-angle glaucoma
Mitchell, P., Leung, H., Wang, J. J., Rochtchina, E., Lee, A. J., Wong, T. Y., & Klein, R. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.08.015 · Cited by 269
Retinal Oxidative Stress Induced by High Intraocular Pressure
Moreno, M. C., Campanelli, J., Sande, P., Sáenz, D. A., Keller Sarmiento, M. I., & Rosenstein, R. E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.001 · Cited by 265
WEI, Y., LU, C., LEE, H., PANG, C., & MA, Y. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09899.x · Cited by 265
Brown, M. D., Trounce, I. A., Jun, A. S., Allen, J. C., & Wallace, D. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006476200 · Cited by 260
Self-citationApoptosis in neurodegenerative diseases: the role of mitochondria
Tatton, W. G., & Olanow, C. W. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00167-4 · Cited by 257
The Distribution of Mitochondrial Activity in Relation to Optic Nerve Structure
Bristow, E. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.791 · Cited by 243
Autoantibodies to small heat shock proteins in glaucoma.
Tezel, G., Seigel, G. M., & Wax, M. B. (1998) · PubMed · Cited by 241
Mitochondrial DNA repair pathways
Croteau, D. L., Stierum, R. H., & Bohr, V. A. (1999) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00025-7 · Cited by 240
Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial
Mariotti, C., Solari, A., Torta, D., Marano, L., Fiorentini, C., & Di Donato, S. (2003) · Neurology · doi:10.1212/01.wnl.0000055872.50364.fc · Cited by 235
Hare, W. A., WoldeMussie, E., Weinreb, R. N., Ton, H., Ruiz, G., Wijono, M., Feldmann, B., Zangwill, L., & Wheeler, L. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0567 · Cited by 222
Oxidative stress and mitochondrial function with aging – the effects of calorie restriction
Merry, B. J. (2004) · Aging Cell · doi:10.1046/j.1474-9728.2003.00074.x · Cited by 207
Age-related depletion of the cell population in the human trabecular meshwork
Grierson, I., & Howes, R. C. (1987) · Eye · doi:10.1038/eye.1987.38 · Cited by 188
Caspase-Independent Component of Retinal Ganglion Cell Death, In Vitro
Tezel, G., & Yang, X. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0490 · Cited by 188
A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.49 · Cited by 181
Tezel, G., Luo, C., & Yang, X. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0737 · Cited by 175
Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity
Volbracht, C., Van Beek, J., Zhu, C., Blomgren, K., & Leist, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04787.x · Cited by 174
The Scientific Basis for the Current Treatment of Parkinson's Disease
Olanow, C. W. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104422 · Cited by 170
Free Radicals in Retinal Ischemia*
Bonne, C., Müller, A., & Villain, M. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00357-1 · Cited by 169
Sanz, A., Caro, P., Ibañez, J., Gómez, J., Gredilla, R., & Barja, G. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-4131-0 · Cited by 165
Barron, M. J. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.027664 · Cited by 164
Effects of OPA1 mutations on mitochondrial morphology and apoptosis: Relevance to ADOA pathogenesis
Olichon, A., Landes, T., Arnauné‐Pelloquin, L., Emorine, L. J., Mils, V., Guichet, A., Delettre, C., Hamel, C., Amati‐Bonneau, P., Bonneau, D., et al. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20950 · Cited by 163
Varicosities of Intraretinal Ganglion Cell Axons in Human and Nonhuman Primates
Wang, L., Dong, J., Cull, G., Fortune, B., & Cioffi, G. A. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0333 · Cited by 161
HENNEBERRY, R. C., NOVELLI, A., COX, J. A., & LYSKO, P. G. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb12512.x · Cited by 157
Nucci, C., Tartaglione, R., Rombolà, L., Morrone, L. A., Fazzi, E. M., & Bagetta, G. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.06.002 · Cited by 154
Ju, W.-K., Liu, Q., Kim, K.-Y., Crowston, J. G., Lindsey, J. D., Agarwal, N., Ellisman, M. H., Perkins, G. A., & Weinreb, R. N. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0573 · Cited by 138
Self-citationHare, W. A., WoldeMussie, E., Lai, R., Ton, H., Ruíz, G., Feldmann, B., Wijono, M., Chun, T., & Wheeler, L. A. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(01)00200-4 · Cited by 131
Osborne, N. N., Lascaratos, G., Bron, A. J., Chidlow, G., & Wood, J. P. M. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.082230 · Cited by 122
Lifespan and mitochondrial control of neurodegeneration
Wright, A. F., Jacobson, S. G., Cideciyan, A. V., Roman, A. J., Shu, X., Vlachantoni, D., McInnes, R. R., & Riemersma, R. A. (2004) · Nature Genetics · doi:10.1038/ng1448 · Cited by 111 · cited 1×
“Genetic and acquired mitochondrial dysfunction have been shown to play a role in physiologic aging and in the pathogenesis of a number of neurodegenerative diseases including Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, Huntington disease, and in mitochondrial diseases such as mitochondrial enc…”
BackgroundMitochondrial Disease: Mutations and Mechanisms
McKenzie, M., Liolitsa, D., & Hanna, M. G. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014829.42364.dd · Cited by 106
Increased Expression of Iron-Regulating Genes in Monkey and Human Glaucoma
Farkas, R. H. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0872 · Cited by 101
Estévez, Á. G., Stutzmann, J. M., & Barbeito, L. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00186-o · Cited by 96
Pang, I.-H., Johnson, E. C., Jia, L., Cepurna, W. O., Shepard, A. R., Hellberg, M. R., Clark, A. F., & Morrison, J. C. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0829 · Cited by 94
MK801—a neuroprotectant in rat hypertensive eyes
Chaudhary, P., Ahmed, F. A. K. M., & Sharma, S. C. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00212-1 · Cited by 81
Production of homoplasmic xenomitochondrial mice
McKenzie, M., Trounce, I. A., Cassar, C. A., & Pinkert, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303184101 · Cited by 70
Self-citationKanki, R., Nakamizo, T., Yamashita, H., Kihara, T., Sawada, H., Uemura, K., Kawamata, J., Shibasaki, H., Akaike, A., & Shimohama, S. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.044 · Cited by 63
Zini, R., Morin, C., Bertelli, A., Bertelli, A. A. E., & Tillement, J. P. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02161-6 · Cited by 50
Differential production of superoxide by neuronal mitochondria
Hoegger, M. J., Lieven, C. J., & Levin, L. A. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-4 · Cited by 48
Apoptosis and anti-apoptosis signalling in glaucomatous retinopathy.
Tatton, W. G., Chalmers-Redman, R. M. E., & Tatton, N. A. (2001) · PubMed · Cited by 47
Calandrella, N., Scarsella, G., Pescosolido, N., & Risuleo, G. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9407-0 · Cited by 34
Rustin, P., Bonnet, D., Rötig, A., Münnich, A., Sidi, D., Mariotti, C., Taroni, F., Donato, S. D., Filla, A., & Moss, A. J. (2004) · Cited by 22
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
The molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
Schapira, A. H. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61305-6 · Cited by 494
Energy metabolism of the visual system
Wong-Riley, M. (2010) · Eye and Brain · doi:10.2147/eb.s9078 · Cited by 461
Resveratrol: A miraculous natural compound for diseases treatment
Koushki, M., Amiri‐Dashatan, N., Ahmadi, N., Abbaszadeh, H., & Rezaei‐Tavirani, M. (2018) · Food Science & Nutrition · doi:10.1002/fsn3.855 · Cited by 316
Metadata
- Authors
- Kong, G. Y. X., Van Bergen, N. J., Trounce, I. A., & Crowston, J. G.
- Venue
- Journal of Glaucoma
- Published
- 2009-02
- Volume
- 18
- Issue
- 2
- Pages
- 93-100
- ISSN
- 1057-0829 (ISSN-L)
- OpenAlex
- W1966110033
- Cited by
- 261
- References
- 86
- FWCI
- 18.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.